Filing Details
- Accession Number:
- 0001104659-16-121466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-16 20:33:51
- Reporting Period:
- 2016-05-12
- Filing Date:
- 2016-05-16
- Accepted Time:
- 2016-05-16 20:33:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1660719 | Aralez Pharmaceuticals Inc. | ARLZ | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1649483 | J Scott Charles | C/O Aralez Pharmaceuticals Inc., 151 Steeles Avenue East Milton, Ontario A6 L9T 1Y1 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, Without Par Value | Acquisiton | 2016-05-12 | 50,000 | $3.49 | 213,368 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
